Friday, 22.4.2016       

Notes For Authors

  Manuscripts are considered with the understanding that no part of the work has been published previously in print or electronic format and the paper is not under consideration by another publication or electronic medium. Prior publication could include, but is not limited to, deposition of all or part of the data in a publicly-accessible preprint or poster repository. Questions related to this policy should be directed to the editors. Related manuscripts that have been submitted elsewhere during the period of revision must accompany revised manuscripts. Failure to provide copies of related manuscripts under consideration elsewhere may delay the review process and may be grounds for rejection. Under no circumstances will any paper be considered that contains any data that have been submitted for publication elsewhere.

Authorship
  The corresponding author is responsible for ensuring that all appropriate contributors are listed as authors and that all authors have agreed to the manuscript’s content and its submission to CCR. In a case where we become aware of an authorship dispute, authorship must be approved in writing by all of the parties.

Conflict of Interest
  A conflict of interest exists when an author, reviewer, or editor has financial or personal relationships with other persons or organizations that may inappropriately influence or bias his or her actions. There is a potential for a conflict of interest whether or not an individual believes that a relationship affects his or her scientific judgment. Conflicts can occur as the result of employment, consultancies, stock ownership, honoraria, paid expert testimony or opinions, personal and family relationships, or academic competitive pressures.

Potential Author Conflicts
  Authors are responsible for disclosing any and all financial and personal relationships between themselves and others that might bias, or be perceived to bias, their work. When submitting a manuscript to CCR, authors must complete the Mandatory Checklist form, which asks for full disclosure of any potential conflicts of interest. Here authors must state whether potential conflicts do or do not exist. Financial arrangements between any author and any company whose product or competing product plays a prominent role in the manuscript must be noted on both the Mandatory Checklist and the title page of the manuscript. If the manuscript is accepted, the CCR editors will decide whether to publish information about potential conflicts. A statement either noting the potential conflict(s) or informing readers that none were disclosed will appear on the article.

Potential conflicts related to sponsorship or financial support
  Authors should describe the role of the study sponsor(s), if any, in study design, data collection, analysis, and interpretation, and the writing of the report. If the sponsor(s) had no such involvement, this should be clearly stated. Authors must attest that they had full access to all of the data in the study, and that they take complete responsibility for the integrity of the data and the accuracy of the data analysis.

Potential Reviewer Conflicts
  Editors will not select peer reviewers who have potential conflicts of interest. Authors may provide editors with the names of persons they feel should not review their manuscript, because of a potential conflict. However, when possible, authors should explain the reason(s) for their concerns. Reviewers must disclose any conflicts that could bias their opinions, and they should disqualify themselves from reviewing when appropriate.

Potential Editor Conflicts
  Editors who make final decisions about manuscripts must have no personal, professional, or financial involvement with any of the subject matter in manuscripts they might judge. When the editor-in-chief (EIC) has a conflict of interest with authors of a new submission, but the co-editor (CE) does not have a conflict, the EIC assigns the paper to the co-EIC who does not have a conflict
  If the co-EIC decides the paper should be rejected without peer review, he/she asks another Editorial Board Member (EBM) (who also has no conflict) for a second opinion. If both agree, the paper is rejected without further review.
  When it has been decided that a manuscript should be peer reviewed, the co-EIC assigns it to reviewers. At least 2 reviews are obtained. If the reviewers are fundamentally in agreement, then the co-EIC may make the decision on the manuscript. If peer reviews differ, the co-EIC may ask 1 or more Editorial Board Members without a conflict for opinions before making his/her decision.

  1. Should both the co-EICs have a conflict with authors of a new submission:
The co-EICs assign the paper to an Associate Editor (AE) who does not have a conflict. The AE assigns the manuscript to reviewers. At least 2 reviews are obtained. If the reviewers are fundamentally in agreement, then the AE may make the decision on the manuscript. If peer reviews differ, the AE may ask 1 or more other Editorial Board Members for opinions before making his/her decision.
  Note that an AE is not given the option of rejecting a manuscript without peer review, since the AE does not have experience in judging the likelihood that a given manuscript will or will not be competitive for publication in CCR.
  If the manuscript is accepted for publication, a statement will appear on the title page saying that an outside editor entirely handled the peer-review and decision-making processes.
  2. When one of the co-EICs is an author of a manuscript submitted to CCR, then that co-EIC is not involved in the peer-review and decision-making processes for this manuscript. The non-author co-EIC oversees the peer review process for this paper.

Statement of Human and Animal Rights
  For manuscripts reporting experiments on human subjects, statements identifying the committee approving the studies and confirming that informed consent was obtained from all subjects must appear in the Methods and Material sections. The statements should indicate whether the procedures followed were in accordance with the institutional and national ethical standards of the responsible committee on human experimentation. If doubt exists whether the research was conducted in accordance with the ethical standards, the authors must explain the rationale for their approach, and demonstrate that the institutional review body (Institutional Review Board, IRB) explicitly approved the doubtful aspects of the study.
For manuscripts reporting experiments on animals, statements identifying the committee approving the studies and confirming that informed consent was obtained from all subjects must appear in the Methods and Material sections. The statements should indicate whether the institutional, national and international guide for the care and use of laboratory animals was followed.

Statement of Informed Consent
  Studies on patients or volunteers require ethics committee approval and informed consent, which should be documented in the paper. Appropriate consents, permissions and releases must be obtained where an author wishes to include case details or other personal information or images of patients and any other individuals in CCR publication. Written consents must be retained by the author and copies of the consents or evidence that such consents have been obtained must be provided to CCR on request. Unless you have written permission from the patient (or, where applicable, the next of kin), the personal details of any patient included in any part of the article and in any supplementary materials (including all illustrations and videos) must be removed before submission.


Copyright form (dowmload)

  Upon acceptance of an article, authors will be asked to transfer copyright. This transfer will ensure the widest possible dissemination of information. A form facilitating transfer of copyright will be provided upon acceptance of the manuscript.  After transfer of copyright, authors retain rights as discussed below.

  The submitting author is responsible for obtaining agreement of all coauthors as well as any sponsors' required consent before submitting a paper. JASEI strongly discourages courtesy authorship. Authors are obliged to cite relevant prior work and they should consider the following points:

  1) Technical papers submitted for publication must advance the state of knowledge and must cite relevant prior work.

  2) The length of a submitted paper should suit its importance, or it should be appropriate to the complexity of the work.

  3) Authors must convince both peer reviewers and the editors about the scientific and technical merit of a paper; knowing that, the standards of proof are higher when extraordinary or unexpected results are reported.

  4) As any scientific progress requires replication, papers submitted for publication must provide sufficient information to allow readers to perform similar experiments or calculations and as well as to use the reported results. Although not everything is needed to be disclosed, a paper must contain new, useable, and fully described information.

   5) Unintelligible English is a valid reason for rejection.

 

Every paper and contribution will become the legal copyright of the publisher unless it is otherwise agreed, in order to have an easily dissemination and to ensure proper policing of use.

Paper Instructions for Authors: CCR_Template.doc

 

Article Formats

Cancer Cell Research publishes two formats of research papers and several other types of articles:


Research Papers
Articles, Reports, Reviews, Minireviews , Letters to the Editor and Other Articles
There is no restriction on the length of the papers. Additional data may be published online as supplementary information at the editors’ discretion.

Submission please contacts the editorial office at editor@cancercellreserch.org.
Cover Letter
Each submission should be accompanied by a cover letter, which should contain a brief explanation of what was previously known, the conceptual advance provided by the findings, and the significance of the findings to a broad readership. A cover letter may contain suggestions for appropriate reviewers and up to three requests for reviewer exclusions. The cover letter is confidential to the editor and will not be seen by reviewers.
General Article Organization and Text Specifications
Research papers in Cancer Cell Research  generally contain the following sections in this order: Title, Authors, Affiliations, Contact Information, Additional title page Footnotes, Abstract, Introduction, Experimental Procedures, Results, Discussion, Acknowledgements, References, Figure and Table Legends, Tables and Figures.  The text should be provided as one document, which may also contain the Tables.  Figures should be provided separately. Supplemental Data should be provided separately.
Gene symbols should be italicized; protein products of the loci are not italicized. Nonstandard abbreviations should be defined when first used in the text. Use of abbreviations should be kept at a minimum. Manuscript file types that we can accept for submission include Word. Required items differ for each article type and are specified during the submission process.
Please note that the text should be double spaced and pages should be numbered. Although summaries need to be entered as text files separate from the body of the manuscript during the online submission process, they should also be included within the manuscript file as usual.
Manuscripts that do not conform to the format guidelines may be returned to the authors for reformatting.

Acceptable Image Formats for Online Submission
Acceptable formats include the following:

    • TIFF (.tif)
    • Encapsulated Postscript (.eps)
    • Portable Document File (.pdf)
    • JPEG (.jpg) – use maximum quality

Please note that we cannot accept Adobe Illustrator, Canvas, or Freehand, files for online submission through Elsevier Editorial System. In addition, we strongly urge that you convert figures from Microsoft Word, Excel, or PowerPont formats to PDF.
For more detailed information and help creating figures, please see following:

TIFF Files (.tif)
TIFF is our preferred format.
Encapsulated Postscript Files (.eps)
As with all vector files (Adobe Illustrator, etc.), when saving as .eps, please be sure to embed all fonts or convert to outlines or paths.
Postscript Files (.ps)
There are many different drawing programs, not all of them supported by the software we use. From almost all of these programs, you should be able to produce a postscript file. When printing, select to print to a (postscript) file, rather than printing by default to a printer. The image must be in portrait orientation. Please be sure to embed all fonts when you save as postscript.
Resolution Requirements
For black and white photographs or micrographs and for any type of graph or drawing in grayscale, the resolution of your file should be a minimum of 500 dpi. For figures that contain color, the resolution should be a minimum of 300 dpi. Please note that figures should meet these resolution numbers at their approximate print sizes.
Color Images
We encourage authors to use colors that can be distinguished by color-blind readers. Please submit your figures in RGB or grayscale—do not convert your files to CMYK. This will optimize their appearance online. However, please be aware that we will convert to CMYK for the print version. If possible, embed the ICC profile.

Submit your paper by email: editor@cancercellresearch.org

Yuour manucript must according to the Template

 
��ҳģ��